Related Experiment Video

Updated: Jun 23, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Silencing an inhibitor unleashes a cytotoxic enzyme

Kimberly A Dickson1, Ronald T Raines

  • 1Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706-1544, USA.

Biochemistry
|May 1, 2009
PubMed

Insights

Ribonuclease inhibitor (RI) protects cells from external ribonucleases. Evolving RI may enhance the cell-killing ability of mammalian ribonucleases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Ribonuclease inhibitor (RI) is a protein that inhibits bovine pancreatic ribonuclease (RNase A).
  • Some amphibian RNase A variants can evade RI and are cytotoxic.
  • The role of RI in protecting cells against exogenous ribonucleases is not fully understood.

Purpose of the Study:

  • To investigate the protective role of RI against exogenous ribonucleases.
  • To explore the potential for enhancing the cytotoxicity of mammalian ribonucleases by manipulating RI interactions.

Main Methods:

  • RNA interference (RNAi) was used to modulate RI levels.
  • Amphibian and mammalian ribonucleases were employed in cellular assays.
  • Cellular protection assays were performed to assess cytotoxicity.

Main Results:

  • RI was demonstrated to protect cells against exogenous ribonucleases.
  • Amphibian RNase A variants that evade RI exhibit cytotoxicity.
  • The study provides evidence for the imperative of RI's molecular evolution.

Conclusions:

  • RI plays a crucial role in cellular defense against exogenous ribonucleases.
  • Understanding RI-ribonuclease interactions can inform strategies for targeted cancer therapy.
  • Enhancing the cytotoxicity of mammalian ribonucleases through RI manipulation is a potential therapeutic avenue.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...